Literature DB >> 8134514

Multiple sclerosis presenting as a pure psychiatric disorder.

K Skegg1.   

Abstract

Using strict diagnostic criteria, 91 patients with multiple sclerosis (MS) were identified in a defined population of 112000. Of these patients, 29 were found to have been referred to a psychiatrist at least once. Their psychiatric records were searched for cases of MS presenting as a pure psychiatric disorder. Only 18 of the 30 psychiatric referrals before the diagnosis of MS involved purely mental symptoms, and there was no reason to suppose most of them to be related to MS. This study highlighted the problem of how to define a true psychiatric presentation of MS. The uncovering of two likely candidates among a population-based sample of 91 supported the existence of such a phenomenon, but it was concluded that the only way to ascertain how often purely mental symptoms might be the first manifestation of MS would be to conduct a large population-based study with controls.

Entities:  

Mesh:

Year:  1993        PMID: 8134514     DOI: 10.1017/s0033291700026374

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  4 in total

1.  Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis.

Authors:  Laura Parisi; Maria A Rocca; Flavia Mattioli; Gianna C Riccitelli; Ruggero Capra; Chiara Stampatori; Fabio Bellomi; Massimo Filippi
Journal:  J Neurol       Date:  2014-06-22       Impact factor: 4.849

2.  Bipolar Disorder in Neurologic Illness.

Authors:  Christopher D. Schneck
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

Review 3.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

4.  Cognitive presentation of multiple sclerosis: evidence for a cortical variant.

Authors:  M Zarei; S Chandran; A Compston; J Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.